These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36253471)

  • 1. A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection.
    Calvert C; Carruthers J; Denny C; Donaghy J; Hillman S; Hopcroft LEM; Hopkins L; Goulding A; Lindsay L; McLaughlin T; Moore E; Pan J; Taylor B; Almaghrabi F; Auyeung B; Bhaskaran K; Gibbons CL; Katikireddi SV; McCowan C; Murray J; O'Leary M; Ritchie LD; Shah SA; Simpson CR; Robertson C; Sheikh A; Stock SJ; Wood R
    Nat Commun; 2022 Oct; 13(1):6124. PubMed ID: 36253471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective cohort study of preconception COVID-19 vaccination and miscarriage.
    Yland JJ; Wesselink AK; Regan AK; Hatch EE; Rothman KJ; Savitz DA; Wang TR; Huybrechts KF; Hernández-Díaz S; Eisenberg ML; Wise LA
    Hum Reprod; 2023 Dec; 38(12):2362-2372. PubMed ID: 37864485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miscarriage after SARS-CoV-2 vaccination: A population-based cohort study.
    Velez MP; Fell DB; Shellenberger JP; Kwong JC; Ray JG
    BJOG; 2024 Mar; 131(4):415-422. PubMed ID: 37973606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection.
    Calvert C; Carruthers J; Denny C; Donaghy J; Hopcroft LEM; Hopkins L; Goulding A; Lindsay L; McLaughlin T; Moore E; Taylor B; Loane M; Dolk H; Morris J; Auyeung B; Bhaskaran K; Gibbons CL; Katikireddi SV; O'Leary M; McAllister D; Shi T; Simpson CR; Robertson C; Sheikh A; Stock SJ; Wood R
    Nat Commun; 2023 Jan; 14(1):107. PubMed ID: 36609574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
    Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
    Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of miscarriage after COVID-19 vaccination before and during pregnancy.
    de Feijter M; van Gelder MMHJ; Vissers LCM; Kant AC; Woestenberg PJ
    Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5724. PubMed ID: 37946587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study.
    Lindsay L; Calvert C; Shi T; Carruthers J; Denny C; Donaghy J; Hopcroft LEM; Hopkins L; Goulding A; McLaughlin T; Moore E; Taylor B; Bhaskaran K; Katikireddi SV; McCabe R; McCowan C; Simpson CR; Robertson C; Sheikh A; Wood R; Stock SJ
    Nat Commun; 2023 Aug; 14(1):5275. PubMed ID: 37644002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 in pregnant women: a systematic review and meta-analysis on the risk and prevalence of pregnancy loss.
    van Baar JAC; Kostova EB; Allotey J; Thangaratinam S; Zamora JR; Bonet M; Kim CR; Mofenson LM; Kunst H; Khalil A; van Leeuwen E; Keijzer J; Strikwerda M; Clark B; Verschuuren M; Coomarasamy A; Goddijn M; van Wely M;
    Hum Reprod Update; 2024 Mar; 30(2):133-152. PubMed ID: 38016805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.
    Sadarangani M; Soe P; Shulha HP; Valiquette L; Vanderkooi OG; Kellner JD; Muller MP; Top KA; Isenor JE; McGeer A; Irvine M; De Serres G; Marty K; Bettinger JA;
    Lancet Infect Dis; 2022 Nov; 22(11):1553-1564. PubMed ID: 35964614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Safety of COVID-19 Vaccination During Preconceptional and Preclinical Pregnancy Period: A National Population Study.
    Gwak E; Kim T; Shin JY; Choi NK; Han S; Lee JY; Choe YJ; Choe SA
    J Korean Med Sci; 2023 Oct; 38(41):e314. PubMed ID: 37873626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    Goldshtein I; Nevo D; Steinberg DM; Rotem RS; Gorfine M; Chodick G; Segal Y
    JAMA; 2021 Aug; 326(8):728-735. PubMed ID: 34251417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccination during pregnancy: coverage and safety.
    Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
    Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants.
    Carlsen EØ; Magnus MC; Oakley L; Fell DB; Greve-Isdahl M; Kinge JM; Håberg SE
    JAMA Intern Med; 2022 Aug; 182(8):825-831. PubMed ID: 35648413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Influenza Vaccination With SARS-CoV-2 Infection and Associated Hospitalization and Mortality Among Patients Aged 66 Years or Older.
    Hosseini-Moghaddam SM; He S; Calzavara A; Campitelli MA; Kwong JC
    JAMA Netw Open; 2022 Sep; 5(9):e2233730. PubMed ID: 36169955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
    Magnus MC; Örtqvist AK; Dahlqwist E; Ljung R; Skår F; Oakley L; Macsali F; Pasternak B; Gjessing HK; Håberg SE; Stephansson O
    JAMA; 2022 Apr; 327(15):1469-1477. PubMed ID: 35323851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes Toward COVID-19 Illness and COVID-19 Vaccination among Pregnant Women: A Cross-Sectional Multicenter Study during August-December 2020.
    Battarbee AN; Stockwell MS; Varner M; Newes-Adeyi G; Daugherty M; Gyamfi-Bannerman C; Tita AT; Vorwaller K; Vargas C; Subramaniam A; Reichle L; Galang RR; Powers E; Lucca-Susana M; Parks M; Chen TJ; Razzaghi H; Dawood FS
    Am J Perinatol; 2022 Jan; 39(1):75-83. PubMed ID: 34598291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study.
    Dick A; Rosenbloom JI; Gutman-Ido E; Lessans N; Cahen-Peretz A; Chill HH
    BMC Pregnancy Childbirth; 2022 Feb; 22(1):166. PubMed ID: 35227233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study.
    Gurol-Urganci I; Jardine JE; Carroll F; Draycott T; Dunn G; Fremeaux A; Harris T; Hawdon J; Morris E; Muller P; Waite L; Webster K; van der Meulen J; Khalil A
    Am J Obstet Gynecol; 2021 Nov; 225(5):522.e1-522.e11. PubMed ID: 34023315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study.
    Mascolo A; di Mauro G; Fraenza F; Gaio M; Zinzi A; Pentella C; Rossi F; Capuano A; Sportiello L
    Front Immunol; 2022; 13():965171. PubMed ID: 36263025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.